ATE169680T1 - 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper - Google Patents

6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Info

Publication number
ATE169680T1
ATE169680T1 AT94900935T AT94900935T ATE169680T1 AT E169680 T1 ATE169680 T1 AT E169680T1 AT 94900935 T AT94900935 T AT 94900935T AT 94900935 T AT94900935 T AT 94900935T AT E169680 T1 ATE169680 T1 AT E169680T1
Authority
AT
Austria
Prior art keywords
pct
mgmt
hybridoma ecacc
nov
date jun
Prior art date
Application number
AT94900935T
Other languages
English (en)
Inventor
Benjamin Fuk Loi Li
Teck Choon Ayi
Original Assignee
Inst Of Molecul & Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecul & Cell Biology filed Critical Inst Of Molecul & Cell Biology
Application granted granted Critical
Publication of ATE169680T1 publication Critical patent/ATE169680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94900935T 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper ATE169680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224888A GB9224888D0 (en) 1992-11-27 1992-11-27 Monoclonal antibody

Publications (1)

Publication Number Publication Date
ATE169680T1 true ATE169680T1 (de) 1998-08-15

Family

ID=10725777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900935T ATE169680T1 (de) 1992-11-27 1993-11-29 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper

Country Status (10)

Country Link
US (1) US5817514A (de)
EP (1) EP0670908B1 (de)
AT (1) ATE169680T1 (de)
AU (1) AU688289B2 (de)
CA (1) CA2149867A1 (de)
DE (1) DE69320364T2 (de)
ES (1) ES2119992T3 (de)
GB (1) GB9224888D0 (de)
SG (1) SG48841A1 (de)
WO (1) WO1994012660A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
CA2422890C (en) * 2000-09-29 2013-04-23 The Johns Hopkins University School Of Medicine Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
DE60237792D1 (de) * 2001-04-10 2010-11-04 Ecole Polytech Verfahren zur Verwendung von O6-Alkylguanin-DNS Alkyltransferasen
EP2338518A1 (de) 2006-01-18 2011-06-29 Merck Patent GmbH Spezifische Krebsbehandlung mit Integrin-Liganden
BRPI0806596A2 (pt) 2007-01-18 2013-07-23 Merck Patent Ges Mit Berchraenkter Haftung medicamento e terapia especÍfica usando-se ligantes de integrina para o tratamento de cÂncer
CA2686848A1 (en) 2007-05-08 2008-11-20 Schering Corporation Methods of treatment using intravenous formulations comprising temozolomide
WO2009154461A1 (en) * 2008-06-19 2009-12-23 Prothix Bv Use of anti-factors xi antibodies for prevention of thrombus formation
MX2011012491A (es) 2009-05-25 2011-12-14 Merck Patent Gmbh Administracion continua de cilengitida en tratamientos contra el cancer.
JP2013532628A (ja) 2010-07-16 2013-08-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 乳癌および／または骨転移の処置に用いるためのペプチド
EP2782936B1 (de) * 2011-11-25 2015-10-07 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Monoklonaler antikörper für den nachweis von snap/clip-markierten proteinen
EP2788478B1 (de) * 2011-12-09 2017-08-23 Institut Pasteur Multiplex-immunoscreening-test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase

Also Published As

Publication number Publication date
WO1994012660A1 (en) 1994-06-09
EP0670908A1 (de) 1995-09-13
GB9224888D0 (en) 1993-01-13
US5817514A (en) 1998-10-06
CA2149867A1 (en) 1994-06-09
AU688289B2 (en) 1998-03-12
ES2119992T3 (es) 1998-10-16
DE69320364D1 (de) 1998-09-17
EP0670908B1 (de) 1998-08-12
AU5570594A (en) 1994-06-22
DE69320364T2 (de) 1998-12-10
SG48841A1 (en) 1998-05-18

Similar Documents

Publication Publication Date Title
Harada et al. Identification of early plasma cells in peripheral blood and their clinical significance
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
MY121464A (en) Antibodies against human cd40
AU2001258567A1 (en) Humanised antibodies to the epidermal growth factor receptor
IL138497A0 (en) Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
DE69840383D1 (de) Ctl epitope des epstein-barr virus
IL126314A0 (en) Monoclonal specific antibodies
NZ508381A (en) Antibodies, antagonists and agonists of the death domain containing receptor 5 (DR5)
ATE169680T1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
SE9103183L (sv) Virus-antikroppskomplex
UA50708C2 (uk) Моноклональне антитіло, яке має здатність розпізнавати антиген, який викликає апоптоз мієлоїдних клітин, фрагмент f(ab)2 моноклонального антитіла, гібридома ferm bp-4382
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
DE69322783D1 (de) Monoklonale Antikörper gegen Glykoprotein P
GR3029483T3 (en) Antibodies against t-cells as therapeutics
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
EP0396505A3 (de) Für einen Immunoglobulin-Isotyp spezifische monoklonale Antikörper
ATE206621T1 (de) Il-8 antagonisten zur behandlung von asthma
ATE288485T1 (de) Monoklonaler antikörper 4g8b4b12 gegen humanes flt3/flk2
HK1011924A1 (en) Monoclonal antibodies to antigens expressed by hematopoietic facilitaroy cells.
ES8707114A1 (es) Procedimiento para la obtencion de un anticuerpo monoclonal anti-alfa-amilasa
GB2284608A (en) 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies
ATE293685T1 (de) Monoklonaler antikörper gegen ratte beta-2- integrin alpha d untereinheit und entsprechendes hybridoma
ATE251643T1 (de) Antikörper 67d2 gegen cd164
Seo et al. Utilization of leucine methyl ester for the generation of hybridomas producing monoclonal antibodies specific to tumor-associated antigens
RU98104739A (ru) Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties